MYOGEN TO SEEK APPROVAL FOR AMBRISENTAN

Biopharmaceutical company Myogen Inc. said Monday it plans to file a new drug application for its blood pressure treatment ambrisentan after positive results from a late-stage clinical trial.
The Houston Chronicle